Gregory MS<p><a href="https://gregory-ms.com/articles/299503/?utm_source=mastodon&utm_medium=article&term=299503" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">gregory-ms.com/articles/299503</span><span class="invisible">/?utm_source=mastodon&utm_medium=article&term=299503</span></a></p><p>The administration of human monoclonal antibodies (mAbs) in preclinical pharmacokinetics and toxicology studies often triggers an immune response, leading to the formation of anti-drug antibodies (ADA). To mitigate this effect, we have recently performed studies using short-term immunosuppressive regimens to induce prolonged immune tolerance towards a human Ab, erenumab, in rats. We report on t...</p><p><a href="https://mastodon.social/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MultipleSclerosis</span></a> <a href="https://mastodon.social/tags/MSchat" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MSchat</span></a> <a href="https://mastodon.social/tags/MS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MS</span></a> <a href="https://mastodon.social/tags/Neurology" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Neurology</span></a></p>